Telomir (TELO) Stock Skyrockets After Cancer Breakthrough—Here’s What It Means for Traders
As of this writing, shares of Telomir Pharmaceuticals (NASDAQ: TELO) are up more than 140% intraday, making it one of the top-performing stocks on the market today. The sudden surge comes on the heels of a major announcement that could mark a turning point in...